Tivic Health Systems Inc (TIVC) 뉴스

CEO Letter to Shareholders Issued by Tivic Health

Provides updates on vagus nerve stimulation (VNS) program and expectations for 2025 Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech...

Form 8-K - Current report

Form PRE 14A - Other preliminary proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 1-A/A - Offering Statement [Regulation A]: [Amend]

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

Pre-recorded Conference Call to Follow at 1:30 p.m. PDT/4:30 p.m EDT Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that...

Tivic Health Validates European Patents in Great Britain, Germany, and France

Patents cover methods used to identify key treatment points and dynamically personalize simulation Tivic Health® Systems, Inc. (Nasdaq: TIVC), a...

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

– Conference Call and Webcast to Follow at 1:30 p.m. PST/4:30 p.m. EST - Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that...